Skip to content

ThermoGenesis Holdings, Inc.

Delisted

CIK 811212fmd_1MBQXJ7CQG8EGSSSTBX9HKBHD7Manufacturing · Laboratory Apparatus & FurnitureTemplate: Standard

Coverage: Jul 01, 2009 to Mar 31, 2024, 56 periods

Income Statement · Annual · Millions · USD
Line itemFY2014FY2015FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023
Total revenues161612151013109109
Cost of revenue101199778688
Gross profit6536261332
Research and development3632322221
Selling, general and administrative111410131088977
Total operating expenses1520141546101011911
Operating income(9)(15)(11)(9)(44)(5)(9)(7)(6)(9)
Interest expense–02113486610
Interest and investment income––––––––––
Other non-operating income (expense)00(8)(21)(0)(0)01(0)0
Income before taxes(9)(15)(19)(30)(46)(10)(17)(12)(12)(19)
Income tax expense(0)––(1)(5)0–00–
Net income from continuing operations(9)––(29)(41)(10)–(12)(12)–
Net income(9)(15)(19)(29)(41)(10)(17)(12)(12)(19)
Net income to common shareholders––––(40)(9)(16)(11)(11)(18)
ThermoGenesis Holdings, Inc. financial statements · FinancialMD